GlassScriptPhysician profile
Brenda May Williams
NPI 1104716026
$387.33
in general payments reported to CMS, 2019-2025
9 companies · $387 in 2025
The $387 reported for 2025 was more than what a typical Acute Care (Nurse Practitioner) provider received nationally (typical 2025 total: $151).
See the full distribution for Acute Care (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2025: $387.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $208 · Education: $179.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $208.33 |
| Education | $179.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $115.10 | 2025 | Enhertu, Datroway |
| Astellas Pharma US INC | $102.27 | 2025 | Xtandi |
| Pharmacosmos Therapeutics INC. | $37.01 | 2025 | Monoferric |
| Abbvie INC. | $28.58 | 2025 | |
| Astellas Pharma Global Development | $25.26 | 2025 | Vyloy |
| Amgen INC. | $21.02 | 2025 | Vectibix |
| Syndax Pharmaceuticals, INC. | $19.93 | 2025 | Revuforj |
| Progenics Pharmaceuticals, INC. | $19.23 | 2025 | |
| Celgene Corporation | $18.93 | 2025 | Reblozyl |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brenda Williams listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.